OTC Reporting Company with High Delivery Control

This listing offers a unique opportunity to acquire a listed OTC reporting company. The company is characterized by its robust delivery infrastructure, achieving a 90% delivery rate through DTC and DWAC, and possesses a significant US shareholder base. This offering is ideal for strategic investors, holding companies, or entities seeking to utilize a public shell for mergers, acquisitions, or other corporate finance activities. Further details regarding the specific operations and financial structure are available upon request.